CD8A and neoplasm: Distinct from C2–C4 SCFAs, formate acts primarily as a folate-dependent one-carbon (1 C) donor to sustain de novo purine synthesis in tumor-infiltrating CD8+ T cells and thereby augment PD-1 blockade in vivo.